alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.2
 RULE
13a-14(a) / 15d-14(a)
CERTIFICATION
  1.
    
    I have reviewed the this Quarterly Report on Form 10-Q of the Company for the quarter
ended September 30, 2009;
 2.
    
    Based on my knowledge, this quarterly report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this quarterly report;
 3.
    
    Based on my knowledge, the financial statements, and other financial information
included in this quarterly report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the
periods presented in this quarterly report;
 4.
    
    The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) for the registrant and we have:
 a.
    
    designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, is made known to us by others
within those entities, particularly during the period in which this report is being
prepared;
 b.
    
    evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and
 c.
    
    disclosed in this report any change in the registrants internal control
over financial reporting that occurred during the registrants most recent fiscal
quarter (the registrants fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
registrants internal control over financial reporting; and
 5.
    
    The registrants other certifying officer and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the registrants
auditors and audit committee of the registrants board of directors (or persons performing
the equivalent functions):
 a.
    
    all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably likely
to adversely affect the registrants ability to record, process, summarize and
report financial information; and
 b.
    
    any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrants internal control over
financial reporting.
 Date:  November 19, 2009
    By:
    /s/ David Bruce HongDavid Bruce HongChief Accounting Officer
# Official Journal C 104/27 M

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 104 |
| | |
| English edition | Information and Notices | Volume 5827 March 2015 |

ISSN 1977-091X

Official Journal

of the European Union

C 104

English edition

Information and Notices

Volume 5827 March 2015

---

| Notice No | Contents | page |
| --- | --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2015/C 104/01 | Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2015 to 28 February 2015(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council) | 1 |
| 2015/C 104/02 | Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 to 28 February 2015(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC) | 10 |

Notice No

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2015/C 104/01

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2015 to 28 February 2015(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

1

2015/C 104/02

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 to 28 February 2015(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

10

---

| EN | |
| --- | --- |

EN
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<CIK>  0001006368
<NAME> MUSE TECHNOLOGIES, INC

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2001
<PERIOD-END>                               DEC-31-2000
<CASH>                                         893,640
<SECURITIES>                                   286,206
<RECEIVABLES>                                3,521,728
<ALLOWANCES>                                 (156,000)
<INVENTORY>                                    219,842
<CURRENT-ASSETS>                             5,998,711
<PP&E>                                       1,732,730
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              12,331,019
<CURRENT-LIABILITIES>                       10,945,102
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       196,556
<OTHER-SE>                                 (1,845,623)
<TOTAL-LIABILITY-AND-EQUITY>                12,331,019
<SALES>                                      3,870,944
<TOTAL-REVENUES>                             3,870,944
<CGS>                                        1,051,475
<TOTAL-COSTS>                                6,679,134
<OTHER-EXPENSES>                               593,109
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             104,761
<INCOME-PRETAX>                            (3,347,947)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (3,347,947)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (3,347,947)
<EPS-BASIC>                                     (0.26)
<EPS-DILUTED>                                   (0.26)



</TABLE>
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

UNITED STATES OF AMERICA,

Plaintiff

- Appellee,

v.

ARTRELLE FRAGHER, AKA Richard Lee

Evans, AKA Fragher Smith, AKA Kenneth

Winzer,

Defendant

- Appellant. No. 20

- 10091

D.C. No. 3:18

- cr

- 00517

- CRB

- 1

MEMORANDUM *

Appeal from the United States District Court

for the Northern District of California

Charles R. Breyer, District Judge, Presiding

Submitted January 20, 2021 * *

Before: McKEOWN, CALLAHAN, and BRESS, Circuit Judges.

Artrelle Fragher appeals from the district court’s judgment and challenges

his guilty

- plea conviction s and concurrent 77

- month sentences for three counts of

possession with intent to distribute a c ontrolled substance

, and three counts of

* This disposition is not appropriate for publication and is not precedent

except as provided by Ninth Circuit Rule 36

- 3.

** The panel unanimously concludes this case is suitable for decision

without oral argument. See Fed. R. App. P. 34(a)(2). 

# FILED

JAN 27 2021

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS2 20

- 10091

distribution and possession with intent to distribute a controlled substance within

1,000 feet of a school, in violation of 21 U.S.C. §§ 841(a)(1), (b)(1)( C), and

860(a)

. Pursuant to Anders v. California , 386 U.S. 738 (1967), Fragher ’s counsel

has filed a brief stating that there are no grounds for relief, along with a motion to

withdraw as counsel of record. Fragher has filed multiple pro se supplemental

brief s

. The government has filed an answering brief.

Fra gher entered into a plea agreement that contained an appeal waiver.

Assuming without deciding that the appeal waiver is not enforceable, our

independent review of the record pursuant to Penson v. Ohio , 488 U.S. 75, 80

(1988), discloses no arguable grounds for relief on direct appeal

. Fragher’s pro se

challenge s to the district court’s jurisdiction are unavailing

. See United States v.

Marks , 530 F.3d 799, 810 (9th Cir. 2008).

Counsel’s motion to withdraw is GRANTED. All other pending motions

and requests are DENIED.

AFFIRMED.
# IMMC.EESC-2019-00680-AC.ENG.xhtml.EESC-2019-00680-00-00-AC-TRA-EN.docx

EN

European Economic and Social Committee

European Economic and Social Committee

NAT/768

NAT/768

Rules relating to the EMFF post Brexit

Rules relating to the EMFF post Brexit

OPINION 


  European Economic and Social Committee


  Proposal for a Regulation of the European Parliament and of the Council amending Regulation (EU) No 508/2014 as regards certain rules relating to the European Maritime and Fisheries Fund by reason of the withdrawal of the United Kingdom from the Union
  [COM(2019) 48 final – 2019/0009(COD)]

OPINION

European Economic and Social Committee

Proposal for a Regulation of the European Parliament and of the Council amending Regulation (EU) No 508/2014 as regards certain rules relating to the European Maritime and Fisheries Fund by reason of the withdrawal of the United Kingdom from the Union
  [COM(2019) 48 final – 2019/0009(COD)]

Referral

| Referral | European Parliament, 30/01/2019


  Council of the European Union, 06/02/2019 |
| --- | --- |
| Legal basis | Articles 43(2) and 304 of the Treaty on the Functioning of the European Union |
| Section responsible | Section for Agriculture, Rural Development and the Environment |
| Adopted at plenary session | 20/02/2019 |
| Plenary session No | 541 |
| Outcome of vote
  (for/against/abstentions) | 159/0/2 |

Referral

European Parliament, 30/01/2019

European Parliament, 30/01/2019

Council of the European Union, 06/02/2019

Council of the European Union, 06/02/2019

Legal basis

Legal basis

Articles 43(2) and 304 of the Treaty on the Functioning of the European Union

Articles 43(2) and 304 of the Treaty on the Functioning of the European Union

Section responsible

Section responsible

Section for Agriculture, Rural Development and the Environment

Section for Agriculture, Rural Development and the Environment

Adopted at plenary session

Adopted at plenary session

20/02/2019

20/02/2019

Plenary session No

Plenary session No

541

541

Outcome of vote
  (for/against/abstentions)

Outcome of vote
  (for/against/abstentions)

159/0/2

159/0/2

Since the Committee unreservedly endorses the content of the proposal and feels that it requires no comment on its part, it decided, at its 541st plenary session of 20 and 21 February 2019 (meeting of 20 February), by 159 votes to 0 with 2 abstentions, to issue an opinion endorsing the proposed text.

Since the Committee unreservedly endorses the content of the proposal and feels that it requires no comment on its part, it decided, at its 541st plenary session of 20 and 21 February 2019 (meeting of 20 February), by 159 votes to 0 with 2 abstentions, to issue an opinion endorsing the proposed text.

Brussels, 20 February 2019.

Brussels, 20 February 2019.

Luca Jahier
  The president of the European Economic and Social Committee

_____________
**EXHIBIT ITEM 32.2**

 

SECTION 906 CERTIFICATION

 

Thecertification set forth below is being submitted to the Securities and ExchangeCommission solely for the purpose of complying with Section 1350 ofChapter 63 of Title 18 of the United States Code.

 

December 5,2008

 

BruceN. Warner, the Chief Financial Officer of Northern California Bancorp, Inc.certifies:

 

c.               thatthis quarterly report  on Form 10-Q/AAmendment 1  for the period ended September 30,2008 fully complies with the requirements of section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

 

d.              thatinformation contained in this Form 10-Q/A Amendment 1  for the period ended September 30, 2008fairly presents, in all material respects, the financial condition and resultsof operations of Northern California Bancorp, Inc.

 

 
|   |   | /s/ Bruce N. Warner           |
|--------|--------|-------------------------------|
|   |   | Bruce N. Warner               |
|   |   | Chief Financial Officer  and  |
|   |   | Principal  Accounting Officer |

 

----
#### UNITED STATES of America, Plaintiff-Appellee v. Gumaro ALMANZA, Defendant-Appellant

No. 16-50396 Summary Calendar

United States Court of Appeals, Fifth Circuit.

Filed January 29, 2018

Joseph H. Gay, Jr., Elizabeth' Beren-guer, Assistant U.S. Attorneys, U.S. Attorney’s Office, Western District of Texas, San Antonio, TX, for Plaintiff-Appellee

John Andrew Kuchera, Waco, TX, for Defendant-Appellant

Before KING, ELROD, and HIGGINSON, Circuit Judges.

PER CURIAM; *

Gumaro Almanza pleaded guilty, pursuant to a written plea agreement, to conspiracy to possess with intent to distribute 50 grams or more of methamphetamine. He was sentenced within the Guidelines to 168 months of imprisonment, to be followed by five years of supervised release. The plea agreement contained an appeal waiver provision, which the Government now seeks to enforce. Almanza, however, contends that the waiver is ineffective because the Government fraudulently induced him to enter a plea agreement that erroneously indicated he might be eligible for safety valve relief. Therefore, Almanza argues, the Government breached the plea agreement and this court should correct errors in the special conditions of his supervised release.

There is no indication of fraudulent inducement in this case. Under the circumstances here, the Government could not determine whether the district court would reach the legal conclusion *<*that Almanza was ineligible for safety valve relief. *See United States v. Bautista-Montelongo,*618 F.3d 464, 466 (5th Cir. 2010). Moreover, the record does not show that the Government made any promise (other than those in the plea agreement), threat, misrepresentation or otherwise improperly induced Almanza to enter into the .plea agreement. Almanza knowingly and voluntarily entered the plea agreement without any improper inducement. *United States v. McKinney,*406 F.3d 744, 746 (5th Cir. 2005).

Accordingly, the appeal is DISMISSED.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.
**EXHIBIT32.1**

**CERTIFICATIONOF CHIEF EXECUTIVE OFFICER**

**Pursuantto Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)**

The undersignedexecutive officer of First Federal Bancshares of Arkansas, Inc. (the “Registrant”)hereby certifies that the Registrant’s Form 10-Q for the three and nine monthsended September 30, 2006 fully complies with the requirements of Section 13(a)or 15(d) of the Securities Exchange Act of 1934 and that the informationcontained therein fairly presents, in all material respects, the financialcondition and results of operations of the Registrant.

 
|              |   | /s/Larry J. Brandt      |
|--------------|--------|-------------------------|
|    |   | Larry J. Brandt         |
|    |   | Chief Executive Officer |

 

Date: October 26,2006

----
#### Niki-Alexander SHETTY, FKA Satish Shetty, Plaintiff-Appellant, v. The BANK OF NEW YORK MELLON as Trustee FOR the CERTIFICATE-HOLDERS CWALT, INC. ALTERNATIVE LOAN TRUST 2005-43 MORTGAGE PASS-THROUGH CERTIFICATES, SERIES 2005-43, a fictitious entity formerly known as The Bank of New York; et al., Defendants-Appellees.

*402No. 17-55342

United States Court of Appeals, Ninth Circuit.

Submitted December 18, 2017 *

Filed December 26, 2017

Niki-Alexander Shetty, Pro Se

Joshua Ryan Hernandez, Esquire, Attorney, Joan Carol Spaeder-Younkin, Esquire, Attorney, Wright, Finlay *&*Zak, LLP, Newport Beach, CA, for Defendant-Appellee

Before: WALLACE, SILVERMAN, and BYBEE, Circuit Judges.

*

**The panel unanimously concludes this case is suitable for decision without oral argument. *See*Fed. R. App. P. 34(a)(2).

MEMORANDUM **

Niki-Alexander Shetty, FKA Satish Shetty, appeals pro se from the district court’s judgment dismissing his diversity action alleging pre-foreclosure claims. We have jurisdiction under 28 U.S.C. § 1291. We review de novo a dismissal under Federal Rule of Civil Procedure 12(b)(6), and we may affirm on any basis supported by the record. *Thompson v. Paul,*547 F.3d 1055, 1058-59 (9th Cir. 2008). We affirm.

Dismissal of Shett/s action was proper because Shetty failed to allege facts sufficient to “state a claim that is plausible on its face.” *Ashcroft v. Iqbal,*556 U.S. 662, 677-78, 129 S.Ct. 1937, 173 L.Ed.2d 868 (2009) (explaining that “[a] pleading that offers labels and conclusions” or “naked assertions devoid of further factual enhancement” is insufficient to survive a motion to dismiss (citation and internal quotation marks omitted)).

We do not consider matters not specifically and distinctly raised and argued in the opening brief or arguments raised for the first time on appeal. *See Padgett v. Wright,*587 F.3d 983, 985 n.2 (9th Cir. 2009).

Appellee The Bank of New York Mellon’s request for judicial notice (Docket Entry No. 15) is denied as unnecessary.

AFFIRMED.

**

 This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.
EXHIBIT 32.1

PROTALIX BIOTHERAPEUTICS, INC.

CERTIFICATION

In connection with the quarterly report of Protalix BioTherapeutics, Inc. (the Company) on Form 10-Q for the period ended March 31, 2008 as filed with the Securities and Exchange Commission (the Report), I, David Aviezer, President and Chief Executive Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, filed with the Securities and Exchange Commission.

Date: May 6, 2008



/s/ David AviezerDavid Aviezer, Ph.D.President and Chief Executive Officer






---
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AS OF MARCH 31, 1997 AND THE CONSOLIDATED STATEMENT
OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 1997 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                          46,595
<SECURITIES>                                 1,031,731
<RECEIVABLES>                                1,748,331
<ALLOWANCES>                                    20,841
<INVENTORY>                                    659,044
<CURRENT-ASSETS>                             3,573,285
<PP&E>                                       1,851,101
<DEPRECIATION>                                 482,603
<TOTAL-ASSETS>                               5,034,802
<CURRENT-LIABILITIES>                        1,398,772
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     6,136,445
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 5,034,802
<SALES>                                      1,861,359
<TOTAL-REVENUES>                             1,861,359
<CGS>                                        1,159,923
<TOTAL-COSTS>                                  765,134
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              24,324
<INCOME-PRETAX>                               (39,374)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (39,374)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (39,374)
<EPS-PRIMARY>                                   (0.01)
<EPS-DILUTED>                                   (0.01)
        

</TABLE>
# C_2009183EN.01S00301.xml

| 5.8.2009 | EN | Official Journal of the European Union | C 183/s3 |
| --- | --- | --- | --- |

5.8.2009

EN

Official Journal of the European Union

C 183/s3

---

NOTICE

NOTICE

On 5 August 2009, in Official Journal of the European Union C 183 A, the ‘Common catalogue of varieties of agricultural plant species — Sixth supplement to the 27th complete edition’ will be published.

Official Journal of the European Union

Subscribers to the Official Journal may obtain the same number of copies and language versions of this Official Journal as those to which they subscribe free of charge. They are requested to return the attached order form, duly completed and bearing their subscription registration number (code appearing on the left of each label and beginning with: O/...). This Official Journal will remain available free of charge for one year from the date of its publication.

Non-subscribers can order this Official Journal against payment from one of our sales offices (see http://publications.europa.eu/others/sales_agents_en.html).

This Official Journal — like all Official Journals (L, C, CA, CE) — can be consulted free of charge online at http://eur-lex.europa.eu

Image

---
<PAGE>

                                                                   EXHIBIT 4.1.1

                            CERTIFICATE OF AMENDMENT

                                       OF

                AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

                                       OF

                       DAISYTEK INTERNATIONAL CORPORATION

                            (A DELAWARE CORPORATION)

It is hereby certified that:

1. The name of the corporation (hereinafter called the "Corporation") is
Daisytek International Corporation.

2. The Amended and Restated Certificate of Incorporation of the Corporation is
hereby amended by striking out Article FOURTH of Section 4 thereof and by
substituting in lieu of said Article the following new Article FOURTH:

"The total number of shares which the Corporation shall have authority to issue
is Twenty-one Million (21,000,000) shares, consisting of One Million (1,000,000)
shares of Preferred Stock, of a par value of One Dollar ($1.00) per share
(hereinafter called "Preferred Stock"), and Twenty Million (20,000,000) shares
of Common Stock, of the par value of One Cent ($.01) per share (hereinafter
called "Common Stock")."

3. The amendment of the Amended and Restated Certificate of Incorporation herein
certified has been duly adopted in accordance with the provisions of Section 242
of the General Corporation Law of the State of Delaware.

SIGNED ON AUGUST 2, 1996.

                                        DAISYTEK INTERNATIONAL CORPORATION

                                        By: MARK C. LAYTON, PRESIDENT

                                        ATTEST:

                                        By: HARVEY ACHATZ, SECRETARY